UNITED HEALTH CARE SALE OF DPS WILL NET PROCEEDS OF $1.4 BIL.
UNITED HEALTH CARE SALE OF DPS WILL NET PROCEEDS OF $1.4 BIL. the Minneapolis firm said in a May 27 announcement of the final deal with SmithKline Beecham. The original full price of the plan by SB to purchase the pharmacy benefit manager Diversified Pharmaceutical Services was $2.3 bil. ("The Pink Sheet" May 9, p. 10).
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth